Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Leif Erik Sander"'
Autor:
Henning Gruell, Kanika Vanshylla, Michael Korenkov, Pinkus Tober-Lau, Matthias Zehner, Friederike Münn, Hanna Janicki, Max Augustin, Philipp Schommers, Leif Erik Sander, Florian Kurth, Christoph Kreer, Florian Klein
Publikováno v:
Cell hostmicrobe. 30(9)
SARS-CoV-2 neutralizing antibodies play a critical role in COVID-19 prevention and treatment but are challenged by viral evolution and the emergence of novel escape variants. Importantly, the recently identified Omicron sublineages BA.2.12.1 and BA.4
Autor:
Lucie, Loyal, Julian, Braun, Larissa, Henze, Beate, Kruse, Manuela, Dingeldey, Ulf, Reimer, Florian, Kern, Tatjana, Schwarz, Maike, Mangold, Clara, Unger, Friederike, Dörfler, Shirin, Kadler, Jennifer, Rosowski, Kübrah, Gürcan, Zehra, Uyar-Aydin, Marco, Frentsch, Florian, Kurth, Karsten, Schnatbaum, Maren, Eckey, Stefan, Hippenstiel, Andreas, Hocke, Marcel A, Müller, Birgit, Sawitzki, Stefan, Miltenyi, Friedemann, Paul, Marcus A, Mall, Holger, Wenschuh, Sebastian, Voigt, Christian, Drosten, Roland, Lauster, Nils, Lachman, Leif-Erik, Sander, Victor M, Corman, Jobst, Röhmel, Lil, Meyer-Arndt, Andreas, Thiel, Claudia, Giesecke-Thiel
Publikováno v:
Science (New York, N.Y.). 374(6564)
The functional relevance of preexisting cross-immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a subject of intense debate. Here, we show that human endemic coronavirus (HCoV)–reactive and SARS-CoV-2–cross-reactive CD4
Autor:
Kanika Vanshylla, Chengcheng Fan, Marie Wunsch, Nareshkumar Poopalasingam, Matthijs Meijers, Christoph Kreer, Franziska Kleipass, Denis Ruchnewitz, Meryem S. Ercanoglu, Henning Gruell, Friederike Münn, Kai Pohl, Hanna Janicki, Tobias Nolden, Simone Bartl, Saskia C. Stein, Max Augustin, Felix Dewald, Lutz Gieselmann, Philipp Schommers, Thomas F. Schulz, Leif Erik Sander, Manuel Koch, Marta Łuksza, Michael Lässig, Pamela J. Bjorkman, Florian Klein
Publikováno v:
Cell Host & Microbe
Cell Host Microbe
Cell Host Microbe
A fraction of COVID-19 convalescent individuals mount a potent antibody response to SARS-CoV-2 with cross-reactivity to SARS-CoV-1. To uncover their humoral response in detail, we performed single B-cell analysis from 10 SARS-CoV-2 elite neutralizers